Hamel Lawrence G 4
4 · ACELRX PHARMACEUTICALS INC · Filed Feb 13, 2020
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Tax Payment
Common Stock
2020-02-11$1.71/sh−5,613$9,598→ 127,769 total
Holdings
- 29,795(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.